Establishing the cost-effectiveness of statins in the primary prevention of CHD using a quasi Markov model

被引：0
|
作者：
Dewilde, S [1 ]
Davies, A [1 ]
Hutton, J [1 ]
机构：
[1] MEDTAP Int, London, England
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61700-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：664 / 665
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of primary prevention of myocardial infarction using statins in Germany
    Lauterbach, KW
    Danner, M
    [J]. ATHEROSCLEROSIS XI, 1998, 1155 : 933 - 939
  • [2] Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
    Erickson, Kevin F.
    Japa, Sohan
    Owens, Douglas K.
    Chertow, Glenn M.
    Garber, Alan M.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1250 - 1258
  • [3] Cost-effectiveness of statins for primary prevention of coronary heart disease in Japan
    Ikeda, Shunya
    Kobayashi, Makoto
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S225 - S226
  • [4] Cost-effectiveness of statins for primary and secondary prevention: A continuum of risk model linking WOSCOPs and care
    Caro, JJ
    Klittich, W
    McGuire, A
    L'Italien, G
    O'Brien, J
    Huttin, C
    Ehreth, J
    [J]. ATHEROSCLEROSIS, 1999, 144 : 25 - 25
  • [5] Cost-effectiveness of statins
    Reckless, JPD
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (04) : 351 - 356
  • [6] Cost-effectiveness of statins
    Huse, DM
    Russell, MW
    Miller, JD
    Kraemer, DF
    D'Agostino, RB
    Ellison, RC
    Hartz, SC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (11): : 1357 - 1363
  • [7] Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium
    Neyt, Mattias
    De laet, Chris
    Van Brabandt, Hans
    Franco, Oscar
    Ramaekers, Dirk
    [J]. ACTA CARDIOLOGICA, 2009, 64 (01) : 1 - 10
  • [8] Cost-Effectiveness of Statins for Primary Prevention in Patients Newly Diagnosed with Type 2 Diabetes in The Netherlands
    de Vries, Folgerdiena M.
    Denig, Petra
    Visser, Sipke T.
    Hak, Eelko
    Postma, Maarten J.
    [J]. VALUE IN HEALTH, 2014, 17 (02) : 223 - 230
  • [9] COST-EFFECTIVENESS OF STATINS FOR PRIMARY PREVENTION IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS IN THE NETHERLANDS
    de Vries, F. M.
    Denig, P.
    Visser, S. T.
    Hak, E.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A526 - A526
  • [10] Cost-effectiveness of prophylactic appendectomy: a Markov model
    Karina Newhall
    Benjamin Albright
    Anna Tosteson
    Elissa Ozanne
    Thadeus Trus
    Philip P. Goodney
    [J]. Surgical Endoscopy, 2017, 31 : 3596 - 3604
12345